{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&_metadata=all&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=0&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "items" : [{"_about" : "http://data.parliament.uk/resources/172790", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172790/answer", "answerText" : {"_value" : "
The Human Fertilisation and Embryology Authority (HFEA) has advised that in its 2014 report the Expert Panel, convened by the HFEA, concluded that, in relation to mosaicism in human morulae:<\/p>
<\/p>
<\/p>
<\/p>
\u201cAlthough experiments are already reported on ES cells and their derivatives with MST, further corroborative experiments would be valuable to demonstrate the degree of heteroplasmic mosaicism in morulae, and to provide data to address whether there was any amplification of mtDNA carried over.\u201d<\/p>
<\/p>
<\/p>
<\/p>
The Panel\u2019s report can be found on the HFEA\u2019s website at:<\/p>
<\/p>
<\/p>
<\/p>
http://www.hfea.gov.uk/6896.html<\/p>
<\/p>
<\/p>
<\/p>
The \u201calready reported\u201d experiments were published in Nature in 2013.<\/p>
<\/p>
<\/p>
<\/p>
At the time of writing the 2014 report, to the Panel\u2019s knowledge, this work had not been published in a peer-reviewed journal. The Department does not routinely publish scientific research conducted independently by others.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:21:10.37Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether the studies recommended by the Human Fertilisation and Embryology Authority's expert review panel in the publication, Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: update, published in March 2013 on mosaicism in human morulae have been concluded; and in which peer-reviewed journal his Department plans to publish the findings of those studies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220195"} , {"_about" : "http://data.parliament.uk/resources/172797", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172797/answer", "answerText" : {"_value" : "
There are already arrangements in place to support children born with conditions relating.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:16:23.13Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether he plans to put contingency arrangements in place to ensure support for recipients of mitochondrial donation techniques in the event of failure or abnormal development in the resulting child.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"} } , "tablingMemberConstituency" : {"_value" : "North Tyneside"} , "tablingMemberPrinted" : [{"_value" : "Mrs Mary Glindon"} ], "uin" : "220183"} , {"_about" : "http://data.parliament.uk/resources/172798", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172798/answer", "answerText" : {"_value" : "
Neither the nuclear DNA or mitochondrial DNA of the patient\u2019s egg is altered during the creation of an embryo during mitochondrial donation treatment, using the maternal spindle transfer (MST) and pro-nuclear transfer (PNT) techniques.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:21:06.287Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment his Department has made of whether eggs used in the creation of embryos through maternal spindle transfer or pronuclear transfer have had their mitochondrial or nuclear genes altered in the process.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"} } , "tablingMemberConstituency" : {"_value" : "North Tyneside"} , "tablingMemberPrinted" : [{"_value" : "Mrs Mary Glindon"} ], "uin" : "220181"} , {"_about" : "http://data.parliament.uk/resources/172801", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172801/answer", "answerText" : {"_value" : "
The Health and Safety Executive (HSE) has run a number of asbestos related awareness raising campaigns including the \u2018Hidden Killer\u2019 campaign in 2008-09; the asbestos \u2018Training Pledge\u2019 in 2010; and the current \u2018Beware Asbestos\u2019 campaign.<\/p>
<\/p>
<\/p>
<\/p>
The \u2018Beware Asbestos\u2019 campaign was launched in October 2014 and is aimed at trades in which people who may disturb asbestos-containing materials in their day to day work. It includes information on identifying asbestos-containing materials and simple, easy to understand advice on how to avoid exposure to asbestos when carrying out a range of common work activities on such materials. It features a smartphone \u2018app\u2019 as a means of delivering this information to.<\/p>
<\/p>
<\/p>
<\/p>
HSE has guidance on the health risks from asbestos, including mesothelioma on its dedicated asbestos related web pages, together with comprehensive information on how to comply with the legal controls covering work with asbestos. This is available at<\/p>
<\/p>
<\/p>
<\/p>